The Latest Breaking News from Benzinga

Some people dream of buying a boat, but this big purchase can become a nightmare if you aren't careful. High earners flocked to Reddit to share some of the biggest regrets they had when they bought their boats.

Vanguard Group, the $10 trillion asset manager, is reportedly weighing plans to let U.S. brokerage clients access cryptocurrency ETFs, according to a report published on Friday.

The Federal Reserve's preferred inflation gauge showed no signs of cooling in August, remaining stubbornly high and reigniting questions over whether the market’s aggressive rate-cut bets are truly justified.

President Donald Trump‘s proposed 100% tariffs on pharmaceuticals could have a smaller impact than initially expected, thanks to certain loopholes. However, the pharmaceutical industry, particularly Big Pharma, remains displeased.

Patients in Southern California are receiving diagnoses and treatment plans generated by artificial intelligence through Akido Labs' ScopeAI proprietary system, according to MIT.

On Thursday, the U.S. Food and Drug Administration (FDA) approved Eli Lilly and Co.’s (NYSE: LLY) Inluriyo (imlunestrant) for adults with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2–), ESR1-mutated advanced or metastatic breast cancer (MBC) whose disease progressed after at least one line of endocrine therapy (ET).

HSBC Holdings’ (NYSE: HSBC) shares are trading relatively flat in the premarket session on Friday.

Harrow, Inc. (NASDAQ: HROW), a U.S.-based provider of ophthalmic disease management solutions, announced on Friday that it has agreed to acquire Melt Pharmaceuticals, Inc., a clinical-stage company developing non-opioid, non-IV sedation therapies for hospitals and outpatient care.

Lamb Weston Holdings, Inc. (NYSE: LW) will release earnings results for the first quarter, before the opening bell on Tuesday, Sept. 30.